AI-generated summary
The authors studied 70 patients with Parkinson's disease and report that laser therapy was associated with reduced neurological deficit and with blood enzyme and immune measures moving toward normal values. They describe the effect as adaptogenic and link it to humoral immunity and antioxidant enzyme activity. The abstract gives no control group, follow-up detail or statistical results, so the findings are limited.
- Participants
- 70
- Who or what was studied
- Patients with Parkinson's disease
- Limits stated in the abstract
- The abstract provides no control group, statistical results, wavelength or dosing details, or follow-up information.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.